Literature DB >> 33430212

Extensive Phylogenetic Analysis of Piscine Orthoreovirus Genomic Sequences Shows the Robustness of Subgenotype Classification.

Marcos Godoy1,2,3, Daniel A Medina1, Rudy Suarez2,4, Sandro Valenzuela2, Jaime Romero5, Molly Kibenge6, Yingwei Wang7, Frederick Kibenge6.   

Abstract

Piscine orthoreovirus (PRV) belongs to the family Reoviridae and has been described mainly in association with salmonid infections. The genome of PRV consists of about 23,600 bp, with 10 segments of double-stranded RNA, classified as small (S1 to S4), medium (M1, M2 and M3) and large (L1, L2 and L3); these range approximately from 1000 bp (segment S4) to 4000 bp (segment L1). How the genetic variation among PRV strains affects the virulence for salmonids is still poorly understood. The aim of this study was to describe the molecular phylogeny of PRV based on an extensive sequence analysis of the S1 and M2 segments of PRV available in the GenBank database to date (May 2020). The analysis was extended to include new PRV sequences for S1 and M2 segments. In addition, subgenotype classifications were assigned to previously published unclassified sequences. It was concluded that the phylogenetic trees are consistent with the original classification using the PRV genomic segment S1, which differentiates PRV into two major genotypes, I and II, and each of these into two subgenotypes, designated as Ia and Ib, and IIa and IIb, respectively. Moreover, some clusters of country- and host-specific PRV subgenotypes were observed in the subset of sequences used. This work strengthens the subgenotype classification of PRV based on the S1 segment and can be used to enhance research on the virulence of PRV.

Entities:  

Keywords:  PRV; Piscine orthoreovirus; genotype; phylogeny; subgenotype

Year:  2021        PMID: 33430212      PMCID: PMC7825714          DOI: 10.3390/pathogens10010041

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  43 in total

1.  Detection of piscine orthoreoviruses (PRV-1 and PRV-3) in Atlantic salmon and rainbow trout farmed in Germany.

Authors:  Mikolaj Adamek; John Hellmann; Agnes Flamm; Felix Teitge; Niccolò Vendramin; Daniel Fey; Karin Riße; Franziska Blakey; Espen Rimstad; Dieter Steinhagen
Journal:  Transbound Emerg Dis       Date:  2018-11-23       Impact factor: 5.005

2.  Piscine reovirus, but not Jaundice Syndrome, was transmissible to Chinook Salmon, Oncorhynchus tshawytscha (Walbaum), Sockeye Salmon, Oncorhynchus nerka (Walbaum), and Atlantic Salmon, Salmo salar L.

Authors:  K A Garver; G D Marty; S N Cockburn; J Richard; L M Hawley; A Müller; R L Thompson; M K Purcell; S Saksida
Journal:  J Fish Dis       Date:  2015-01-29       Impact factor: 2.767

3.  Molecular testing of adult Pacific salmon and trout (Oncorhynchus spp.) for several RNA viruses demonstrates widespread distribution of piscine orthoreovirus in Alaska and Washington.

Authors:  M K Purcell; R L Powers; J Evered; J Kerwin; T R Meyers; B Stewart; J R Winton
Journal:  J Fish Dis       Date:  2017-11-21       Impact factor: 2.767

4.  Prevalence of piscine orthoreovirus and salmonid alphavirus in sea-caught returning adult Atlantic salmon (Salmo salar L.) in northern Norway.

Authors:  A S Madhun; C H Isachsen; L M Omdal; A C B Einen; S Maehle; V Wennevik; E Niemelä; T Svåsand; E Karlsbakk
Journal:  J Fish Dis       Date:  2018-01-31       Impact factor: 2.767

5.  Quantification of piscine reovirus (PRV) at different stages of Atlantic salmon Salmo salar production.

Authors:  Marie Løvoll; Marta Alarcón; Britt Bang Jensen; Torunn Taksdal; Anja B Kristoffersen; Torstein Tengs
Journal:  Dis Aquat Organ       Date:  2012-05-15       Impact factor: 1.802

6.  Piscine orthoreovirus (PRV) replicates in Atlantic salmon (Salmo salar L.) erythrocytes ex vivo.

Authors:  Øystein Wessel; Christel Moræus Olsen; Espen Rimstad; Maria Krudtaa Dahle
Journal:  Vet Res       Date:  2015-03-06       Impact factor: 3.683

7.  Evolution of the Piscine orthoreovirus Genome Linked to Emergence of Heart and Skeletal Muscle Inflammation in Farmed Atlantic Salmon (Salmo salar).

Authors:  Kannimuthu Dhamotharan; Torstein Tengs; Øystein Wessel; Stine Braaen; Ingvild B Nyman; Elisabeth F Hansen; Debes H Christiansen; Maria K Dahle; Espen Rimstad; Turhan Markussen
Journal:  Viruses       Date:  2019-05-22       Impact factor: 5.048

8.  Health Surveillance of Wild Brown Trout (Salmo trutta fario) in the Czech Republic Revealed a Coexistence of Proliferative Kidney Disease and Piscine Orthoreovirus-3 Infection.

Authors:  Ľubomír Pojezdal; Mikolaj Adamek; Eva Syrová; Dieter Steinhagen; Hana Minářová; Ivana Papežíková; Veronika Seidlová; Stanislava Reschová; Miroslava Palíková
Journal:  Pathogens       Date:  2020-07-24

9.  Molecular and Antigenic Characterization of Piscine orthoreovirus (PRV) from Rainbow Trout (Oncorhynchus mykiss).

Authors:  Kannimuthu Dhamotharan; Niccolò Vendramin; Turhan Markussen; Øystein Wessel; Argelia Cuenca; Ingvild B Nyman; Anne Berit Olsen; Torstein Tengs; Maria Krudtaa Dahle; Espen Rimstad
Journal:  Viruses       Date:  2018-04-02       Impact factor: 5.048

10.  Identification of a piscine reovirus-related pathogen in proliferative darkening syndrome (PDS) infected brown trout (Salmo trutta fario) using a next-generation technology detection pipeline.

Authors:  Ralph Kuehn; Bernhard C Stoeckle; Marc Young; Lisa Popp; Jens-Eike Taeubert; Michael W Pfaffl; Juergen Geist
Journal:  PLoS One       Date:  2018-10-22       Impact factor: 3.240

View more
  2 in total

Review 1.  Sleeping With the Enemy? The Current Knowledge of Piscine Orthoreovirus (PRV) Immune Response Elicited to Counteract Infection.

Authors:  Eva Vallejos-Vidal; Felipe E Reyes-López; Ana María Sandino; Mónica Imarai
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

2.  Pan-Piscine Orthoreovirus (PRV) Detection Using Reverse Transcription Quantitative PCR.

Authors:  Julie Zhao; Niccolò Vendramin; Argelia Cuenca; Mark Polinski; Laura M Hawley; Kyle A Garver
Journal:  Pathogens       Date:  2021-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.